FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells

Hong Jian Wei, Jac A. Nickoloff, Wei Hong Chen, Hen Yu Liu, Wen Cheng Lo, Ya Ting Chang, Pan Chyr Yang, Cheng Wen Wu, David F. Williams, Juri G. Gelovani, Win Ping Deng

研究成果: 雜誌貢獻文章

39 引文 (Scopus)

摘要

Several reports suggest that malignant cells generate phenotypic diversity through fusion with various types of stromal cells within the tumor microenvironment. Mesenchymal stem cell (MSC) is one of the critical components in the tumor microenvironment and a promising fusogenic candidate, but the underlying functions of MSC fusion with malignant cell have not been fully examined. Here, we demonstrate that MSCs fuse spontaneously with lung cancer cells, and the latter is reprogrammed to slow growth and stem-like state. Transcriptome profiles reveal that lung cancer cells are reprogrammed to a more benign state upon MSC fusion. We further identified FOXF1 as a reprogramming mediator that contributes not only to the reprogramming toward stemness but also to the p21-regulated growth suppression in fusion progeny. Collectively, MSC fusion does not enhance the intrinsic malignancy of lung cancer cells. The anti-malignant effects of MSC fusion-induced reprogramming on lung cancer cells were accomplished by complementation of tumorigenic defects, including restoration of p21 function and normal terminal differentiation pathways as well as up-regulation of FOXF1, a putative tumor suppressor. Such fusion process raises the therapeutic potential that MSC fusion can be utilized to reverse cellular phenotypes in cancer.
原文英語
頁(從 - 到)9514-9529
頁數16
期刊Oncotarget
5
發行號19
出版狀態已發佈 - 2014

指紋

Cell Fusion
Mesenchymal Stromal Cells
Lung Neoplasms
Tumor Microenvironment
Neoplasms
Stromal Cells
Growth
Transcriptome
Up-Regulation
Phenotype

ASJC Scopus subject areas

  • Oncology

引用此文

Wei, H. J., Nickoloff, J. A., Chen, W. H., Liu, H. Y., Lo, W. C., Chang, Y. T., ... Deng, W. P. (2014). FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget, 5(19), 9514-9529.

FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. / Wei, Hong Jian; Nickoloff, Jac A.; Chen, Wei Hong; Liu, Hen Yu; Lo, Wen Cheng; Chang, Ya Ting; Yang, Pan Chyr; Wu, Cheng Wen; Williams, David F.; Gelovani, Juri G.; Deng, Win Ping.

於: Oncotarget, 卷 5, 編號 19, 2014, p. 9514-9529.

研究成果: 雜誌貢獻文章

Wei, HJ, Nickoloff, JA, Chen, WH, Liu, HY, Lo, WC, Chang, YT, Yang, PC, Wu, CW, Williams, DF, Gelovani, JG & Deng, WP 2014, 'FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells', Oncotarget, 卷 5, 編號 19, 頁 9514-9529.
Wei HJ, Nickoloff JA, Chen WH, Liu HY, Lo WC, Chang YT 等. FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. Oncotarget. 2014;5(19):9514-9529.
Wei, Hong Jian ; Nickoloff, Jac A. ; Chen, Wei Hong ; Liu, Hen Yu ; Lo, Wen Cheng ; Chang, Ya Ting ; Yang, Pan Chyr ; Wu, Cheng Wen ; Williams, David F. ; Gelovani, Juri G. ; Deng, Win Ping. / FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells. 於: Oncotarget. 2014 ; 卷 5, 編號 19. 頁 9514-9529.
@article{89922aca775c47eeb018ce01188c603a,
title = "FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells",
abstract = "Several reports suggest that malignant cells generate phenotypic diversity through fusion with various types of stromal cells within the tumor microenvironment. Mesenchymal stem cell (MSC) is one of the critical components in the tumor microenvironment and a promising fusogenic candidate, but the underlying functions of MSC fusion with malignant cell have not been fully examined. Here, we demonstrate that MSCs fuse spontaneously with lung cancer cells, and the latter is reprogrammed to slow growth and stem-like state. Transcriptome profiles reveal that lung cancer cells are reprogrammed to a more benign state upon MSC fusion. We further identified FOXF1 as a reprogramming mediator that contributes not only to the reprogramming toward stemness but also to the p21-regulated growth suppression in fusion progeny. Collectively, MSC fusion does not enhance the intrinsic malignancy of lung cancer cells. The anti-malignant effects of MSC fusion-induced reprogramming on lung cancer cells were accomplished by complementation of tumorigenic defects, including restoration of p21 function and normal terminal differentiation pathways as well as up-regulation of FOXF1, a putative tumor suppressor. Such fusion process raises the therapeutic potential that MSC fusion can be utilized to reverse cellular phenotypes in cancer.",
keywords = "Cell fusion, FOXF1, Lung cancer cell, Mesenchymal stem cell, P21, Reprogramming",
author = "Wei, {Hong Jian} and Nickoloff, {Jac A.} and Chen, {Wei Hong} and Liu, {Hen Yu} and Lo, {Wen Cheng} and Chang, {Ya Ting} and Yang, {Pan Chyr} and Wu, {Cheng Wen} and Williams, {David F.} and Gelovani, {Juri G.} and Deng, {Win Ping}",
year = "2014",
language = "English",
volume = "5",
pages = "9514--9529",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "19",

}

TY - JOUR

T1 - FOXF1 mediates mesenchymal stem cell fusion-induced reprogramming of lung cancer cells

AU - Wei, Hong Jian

AU - Nickoloff, Jac A.

AU - Chen, Wei Hong

AU - Liu, Hen Yu

AU - Lo, Wen Cheng

AU - Chang, Ya Ting

AU - Yang, Pan Chyr

AU - Wu, Cheng Wen

AU - Williams, David F.

AU - Gelovani, Juri G.

AU - Deng, Win Ping

PY - 2014

Y1 - 2014

N2 - Several reports suggest that malignant cells generate phenotypic diversity through fusion with various types of stromal cells within the tumor microenvironment. Mesenchymal stem cell (MSC) is one of the critical components in the tumor microenvironment and a promising fusogenic candidate, but the underlying functions of MSC fusion with malignant cell have not been fully examined. Here, we demonstrate that MSCs fuse spontaneously with lung cancer cells, and the latter is reprogrammed to slow growth and stem-like state. Transcriptome profiles reveal that lung cancer cells are reprogrammed to a more benign state upon MSC fusion. We further identified FOXF1 as a reprogramming mediator that contributes not only to the reprogramming toward stemness but also to the p21-regulated growth suppression in fusion progeny. Collectively, MSC fusion does not enhance the intrinsic malignancy of lung cancer cells. The anti-malignant effects of MSC fusion-induced reprogramming on lung cancer cells were accomplished by complementation of tumorigenic defects, including restoration of p21 function and normal terminal differentiation pathways as well as up-regulation of FOXF1, a putative tumor suppressor. Such fusion process raises the therapeutic potential that MSC fusion can be utilized to reverse cellular phenotypes in cancer.

AB - Several reports suggest that malignant cells generate phenotypic diversity through fusion with various types of stromal cells within the tumor microenvironment. Mesenchymal stem cell (MSC) is one of the critical components in the tumor microenvironment and a promising fusogenic candidate, but the underlying functions of MSC fusion with malignant cell have not been fully examined. Here, we demonstrate that MSCs fuse spontaneously with lung cancer cells, and the latter is reprogrammed to slow growth and stem-like state. Transcriptome profiles reveal that lung cancer cells are reprogrammed to a more benign state upon MSC fusion. We further identified FOXF1 as a reprogramming mediator that contributes not only to the reprogramming toward stemness but also to the p21-regulated growth suppression in fusion progeny. Collectively, MSC fusion does not enhance the intrinsic malignancy of lung cancer cells. The anti-malignant effects of MSC fusion-induced reprogramming on lung cancer cells were accomplished by complementation of tumorigenic defects, including restoration of p21 function and normal terminal differentiation pathways as well as up-regulation of FOXF1, a putative tumor suppressor. Such fusion process raises the therapeutic potential that MSC fusion can be utilized to reverse cellular phenotypes in cancer.

KW - Cell fusion

KW - FOXF1

KW - Lung cancer cell

KW - Mesenchymal stem cell

KW - P21

KW - Reprogramming

UR - http://www.scopus.com/inward/record.url?scp=84910051160&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910051160&partnerID=8YFLogxK

M3 - Article

C2 - 25237908

AN - SCOPUS:84910051160

VL - 5

SP - 9514

EP - 9529

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 19

ER -